Diabetes and Cancer Risk: A Mendelian Randomization Study

Overview

Journal Int J Cancer

Specialty Oncology

Date 2019 Mar 31

PMID 30927373

Citations 44

Authors

Atsushi Goto

Taiki Yamaji

Norie Sawada

Yukihide Momozawa

Yoichiro Kamatani

Michiaki Kubo

Taichi Shimazu

Manami Inoue

Mitsuhiko Noda

Shoichiro Tsugane

Motoki Iwasaki

Affiliations

Soon will be listed here.

Abstract

Earlier cohort studies using conventional regression models have consistently shown an increased cancer risk among individuals with type 2 diabetes. However, reverse causality and residual confounding due to common risk factors could exist, and it remains unclear whether diabetes per se contributes to cancer development. Mendelian randomization analyses might clarify the true association between diabetes and cancer risk. We conducted a case-cohort study with 10,536 subcohort subjects and 3,541 newly diagnosed cancer cases derived from 32,949 eligible participants aged 40-69 years within the Japan Public Health Center-based Prospective Study. With 29 known type 2 diabetes susceptibility variants, we used an inverse variance-weighted method to estimate hazard ratios for the associations of diabetes with risks of total and site-specific cancers. The hazard ratios of cancer per doubling of the probability of diabetes were 1.03 (95% confidence interval [CI], 0.92-1.15) overall, 1.08 (95% CI: 0.73-1.59) for the pancreas, 0.80 (95% CI: 0.57-1.14) for the liver and 0.90 (95% CI: 0.74-1.10) for the colorectum. Additional analyses, using publicly available large-scale genome-wide association study data on colorectal cancer in Japan, resulted in a narrower CI (hazard ratio: 1.00; 95% CI: 0.93-1.07). In this prospective Mendelian randomization study with a large number of incident cancer cases, we found no strong evidence to support associations between diabetes and overall and site-specific cancer risks. Our findings suggest that there is little evidence to support the genetic role of type 2 diabetes in cancer development in the Japanese population.

Citing Articles

Exploring modifiable risk factors: insights from Mendelian randomization analyses of gastric cancer in East Asian populations.

He W, Tan X, Yang W, Huang D, Zhang H, Liu H Discov Oncol. 2025; 16(1):210.

PMID: 39971821 PMC: 11839552. DOI: 10.1007/s12672-025-01953-1.

Type 2 Diabetes, Obesity and Their Relation to the Risks of Thyroid Cancer.

Grimmichova T, Kuklikova V, Bulanova B, Pacesova P, Vaclavikova E, Moravcova J Physiol Res. 2025; 73(6):1025-1035.

PMID: 39903892 PMC: 11835217.

Osteoporosis and stroke: a bidirectional mendelian randomization study.

He M, Yong H, Cao Z, Li J J Bone Miner Metab. 2025; .

PMID: 39792154 DOI: 10.1007/s00774-025-01579-x.

Comparative analysis of the clinical aspects of colorectal cancer in young adult and older adult patients in Saudi Arabia.

Aldriwesh M, Aljaian A, Alorf K, Bayounis M, Alrayani Y, Philip W Front Oncol. 2024; 14:1460636.

PMID: 39703840 PMC: 11655320. DOI: 10.3389/fonc.2024.1460636.

Identifying the Genetic Associations Between Diabetes Mellitus and the Risk of Vitiligo.

Zhao L, Hu M, Li L Clin Cosmet Investig Dermatol. 2024; 17:2261-2271.

PMID: 39421797 PMC: 11484772. DOI: 10.2147/CCID.S480199.

References

Burgess S, Butterworth A, Thompson S . Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7):658-65. PMC: 4377079. DOI: 10.1002/gepi.21758. View

Hanson R, Muller Y, Kobes S, Guo T, Bian L, Ossowski V . A genome-wide association study in American Indians implicates DNER as a susceptibility locus for type 2 diabetes. Diabetes. 2013; 63(1):369-76. PMC: 3868048. DOI: 10.2337/db13-0416. View

Jostins L, Ripke S, Weersma R, Duerr R, McGovern D, Hui K . Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491(7422):119-24. PMC: 3491803. DOI: 10.1038/nature11582. View

Goto A, Noda M, Sawada N, Kato M, Hidaka A, Mizoue T . High hemoglobin A1c levels within the non-diabetic range are associated with the risk of all cancers. Int J Cancer. 2015; 138(7):1741-53. PMC: 4737277. DOI: 10.1002/ijc.29917. View

Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H . Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet. 2008; 40(9):1092-7. DOI: 10.1038/ng.207. View

Tsugane S, Sawada N . The JPHC study: design and some findings on the typical Japanese diet. Jpn J Clin Oncol. 2014; 44(9):777-82. DOI: 10.1093/jjco/hyu096. View

Carreras-Torres R, Johansson M, Gaborieau V, Haycock P, Wade K, Relton C . The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study. J Natl Cancer Inst. 2017; 109(9). PMC: 5721813. DOI: 10.1093/jnci/djx012. View

Didelez V, Sheehan N . Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. 2007; 16(4):309-30. DOI: 10.1177/0962280206077743. View

Scott L, Mohlke K, Bonnycastle L, Willer C, Li Y, Duren W . A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007; 316(5829):1341-5. PMC: 3214617. DOI: 10.1126/science.1142382. View

10.

Zeggini E, Scott L, Saxena R, Voight B, Marchini J, Hu T . Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008; 40(5):638-45. PMC: 2672416. DOI: 10.1038/ng.120. View

11.

Davey Smith G, Ebrahim S . 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol. 2003; 32(1):1-22. DOI: 10.1093/ije/dyg070. View

12.

Wen W, Zheng W, Okada Y, Takeuchi F, Tabara Y, Hwang J . Meta-analysis of genome-wide association studies in East Asian-ancestry populations identifies four new loci for body mass index. Hum Mol Genet. 2014; 23(20):5492-504. PMC: 4168820. DOI: 10.1093/hmg/ddu248. View

13.

Ward L, Kellis M . HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2011; 40(Database issue):D930-4. PMC: 3245002. DOI: 10.1093/nar/gkr917. View

14.

Hemani G, Zheng J, Elsworth B, Wade K, Haberland V, Baird D . The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018; 7. PMC: 5976434. DOI: 10.7554/eLife.34408. View

15.

Cho Y, Chen C, Hu C, Long J, Ong R, Sim X . Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet. 2011; 44(1):67-72. PMC: 3582398. DOI: 10.1038/ng.1019. View

16.

Prokopenko I, Poon W, Magi R, Prasad B R, Salehi S, Almgren P . A central role for GRB10 in regulation of islet function in man. PLoS Genet. 2014; 10(4):e1004235. PMC: 3974640. DOI: 10.1371/journal.pgen.1004235. View

17.

Kulathinal S, Karvanen J, Saarela O, Kuulasmaa K . Case-cohort design in practice - experiences from the MORGAM Project. Epidemiol Perspect Innov. 2007; 4:15. PMC: 2216006. DOI: 10.1186/1742-5573-4-15. View

18.

Sasazuki S, Charvat H, Hara A, Wakai K, Nagata C, Nakamura K . Diabetes mellitus and cancer risk: pooled analysis of eight cohort studies in Japan. Cancer Sci. 2013; 104(11):1499-507. PMC: 7656560. DOI: 10.1111/cas.12241. View

19.

Yamauchi T, Hara K, Maeda S, Yasuda K, Takahashi A, Horikoshi M . A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet. 2010; 42(10):864-8. DOI: 10.1038/ng.660. View

20.

Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson A . New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010; 42(2):105-16. PMC: 3018764. DOI: 10.1038/ng.520. View